Glucagon-like Peptide-2 Functions as an Anorexigenic Peptide not only in the Central Nervous System but also in the Peripheral Circulation in Broiler Chicks

被引:12
|
作者
Honda, Kazuhisa [1 ]
Shimatani, Tomohiko [1 ]
Aoki, Koji [1 ]
Yamaguchi, Takuya [1 ]
Kondo, Makoto [2 ]
Saneyasu, Takaoki [1 ]
Kamisoyama, Hiroshi [1 ]
机构
[1] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan
[2] Kobe Univ, Fac Agr, Kobe, Hyogo 6578501, Japan
来源
JOURNAL OF POULTRY SCIENCE | 2015年 / 52卷 / 03期
关键词
appetite; brainstem; chickens; hypothalamus; medulla oblongata; PROGLUCAGON-DERIVED PEPTIDE; SUPPRESSES FOOD-INTAKE; TISSUE DISTRIBUTION; SMALL-INTESTINE; MESSENGER-RNA; RECEPTOR; CELLS; ENERGY; LOCALIZATION; EXPRESSION;
D O I
10.2141/jpsa.0150011
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Brain-gut peptides play important roles in the appetite regulatory system in mammals. Glucagon-like peptide (GLP)-1, GLP-2, and oxyntomodulin (OXM) are processed from the same precursor, proglucagon, in both brain and intestines in mammals and birds. We previously showed that intracerebroventricular administration of these three peptides significantly suppressed food intake in chicks. However, peripheral roles of chicken GLP-2 have not yet been investigated, although GLP-2 plays important roles both in central and peripheral regulation of food intake in mammals. The aim of this study is to investigate whether GLP-2 functions as an anorexigenic peptide in both brain and peripheral circulation in chicks. Intracerebroventricular administration of GLP-2 significantly suppressed food intake in chicks. Twenty-four hours of fasting significantly decreased the mRNA level of proglucagon in the medulla oblongata of chicks. These results suggest that GLP-2 functions as anorexigenic peptides in the central nervous system in chicks. In addition, intravenous administration of GLP-2 significantly suppressed food intake in chicks. Lines of evidence suggest that dietary nutrients stimulate the secretion of GLP-2 from L cells in the small intestine in chickens. These findings suggest that GLP-2 functions as both central and peripheral anorexigenic signals in chicks.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 50 条
  • [31] Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2
    L'Heureux, MC
    Brubaker, PL
    ANNALS OF MEDICINE, 2001, 33 (04) : 229 - 235
  • [32] Distribution of glucagon-like peptide-2 in normal colonic tissue
    Caddy, G
    Johnston, C
    Ardill, J
    Pogue, K
    Collins, J
    Gardiner, K
    Watson, P
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (07) : 798 - 799
  • [33] Plasma glucagon-like peptide-2 in cats with chronic enteropathies
    Jugan, Maria C.
    Plattner, Brandon L.
    Ford, Alexandra K.
    Freilich, Leah
    Bieberly, Zackery
    Schermerhorn, Thomas
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2025, 27 (01)
  • [34] Current and potential therapeutic targets of glucagon-like peptide-2
    Austin, Kaori
    Markovic, Melanie A.
    Brubaker, Patricia L.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 31 : 13 - 18
  • [35] Structure, measurement, and secretion of human glucagon-like peptide-2
    Hartmann, B
    Johnsen, AH
    Orskov, C
    Adelhorst, K
    Thim, L
    Holst, JJ
    PEPTIDES, 2000, 21 (01) : 73 - 80
  • [36] Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse
    Yusta, Bernardo
    Matthews, Dianne
    Koehler, Jacqueline A.
    Pujadas, Gemma
    Kaur, Kiran Deep
    Drucker, Daniel J.
    ENDOCRINOLOGY, 2019, 160 (08) : 1950 - 1963
  • [37] Biologic properties and therapeutic potential of glucagon-like peptide-2
    Drucker, DJ
    Boushey, RP
    Wang, F
    Hill, ME
    Brubaker, PL
    Yusta, B
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1999, 23 (05) : S98 - S100
  • [38] Glucagon-like peptide-2: Update of the recent clinical trials
    Jeppesen, PB
    GASTROENTEROLOGY, 2006, 130 (02) : S127 - S131
  • [39] A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro
    Lambeir, AM
    Proost, P
    Scharpé, S
    De Meester, I
    BIOCHEMICAL PHARMACOLOGY, 2002, 64 (12) : 1753 - 1756
  • [40] Different from Glucagon-Like Peptide-1, Glucagon-Like Peptide-2 Is Associated with Obesity and Postprandial Lipemia in Subjects with Diabetes
    Takata, Yasunori
    Kawamura, Ryoichi
    Onuma, Hiroshi
    Osawa, Haruhiko
    DIABETES, 2015, 64 : A177 - A177